Cell Therapies and Bioengineering Conference September 20-22, 2018Mission Bay Conference Center at UCSF, San Francisco, CAWe are excited to present the first conference on Cell Therapies and Bioengineering. This conference will highlight new and upcoming research in this field such as CAR T cell therapies, TCR T cells, Immune cells other than conventional T cells, challenges and opportunities for cell therapies for...
3rd Bioengineering & Translational Medicine Conference September 27-28, 2018Sheraton Boston Hotel, Boston, MAThe 3rd Bioengineering & Translational Medicine Conference will bring together top researchers from academia and industry to discuss advances in the development, clinical and commercial translation of biological technologies. Call for Abstracts open until July 27, 2018 Submit an abstract here "...
2nd Epigenetics and Bioengineering Conference (EpiBio 2018) October 4-6, 2018The Mission Bay Conference Center, San Francisco, CAPresented by the Society for Biological Engineering (SBE), EpiBio 2018 is a forum for engineers and scientists who are applying the tools and techniques of bioengineering to the area of epigenetics. Academic, clinical, and industrial researchers from several disciplines are invited to share their...
CEP: News Update July2018News UpdateNanomaterials Restore Aged Canvases Researchers at Chalmers Univ. of Technology in Göteborg, Sweden, have developed a new method to provide structural support to canvas using nanomaterials. The method, called consolidation, treats the degraded...
Catalyzing Commercialization: A New Generation of Bio-Based Adhesives from Bioadvantaged Monomers June2018Catalyzing CommercializationBiopolymers, produced at least partially from renewable resources, have gained attention as society, industry, and governments realize the need to move away from petroleum-based materials. There are two main types of biopolymers — bioreplacement polymers and bioadvantaged polymers.
Technical Entity Trends: CRISPR: Editing Genes One Sequence at a Time June2018Technical Entity TrendsKeith JosephThe technology known as CRISPR — clustered regularly interspaced short palindromic repeats — has taken the field of synthetic bioengineering by storm. It emerged as a gene-editing tool only five years ago, but has become a familiar presence in the lab.